Hospital Supplies
North America
Updated
Reviewed by Chandani Patel
North America Urinary Incontinence Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Gender, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$3.84 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $6.98 Bn | — | — |
| 2025 (base) | $7.32 Bn | +$335.2 Mn | — |
| 2026 (forecast) | $7.67 Bn | +$351.3 Mn | +4.8% |
| 2027 (forecast) | $8.04 Bn | +$368.1 Mn | +9.8% |
| 2028 (forecast) | $8.42 Bn | +$385.8 Mn | +15.1% |
| 2029 (forecast) | $8.83 Bn | +$404.3 Mn | +20.6% |
| 2030 (forecast) | $9.25 Bn | +$423.7 Mn | +26.4% |
| 2031 (forecast) | $9.70 Bn | +$444.1 Mn | +32.5% |
| 2032 (forecast) | $10.16 Bn | +$465.4 Mn | +38.8% |
| 2033 (forecast) | $10.65 Bn | +$487.7 Mn | +45.5% |
| 2034 (forecast) | $11.16 Bn | +$511.1 Mn | +52.5% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $7.32 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $11.16 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 4.8% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, gender and end user (see all) |
| Key players | Coloplast, BD (Becton, Dickinson), Medtronic, Boston Scientific Corporation, Essity (see all) |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Urinary incontinence devices manage bladder leakage with catheters, pads, slings and nerve stimulation.
Key segments of the urinary Incontinence Devices market include product (Urinary Catheters, Absorbent Products and Slings and Bulking Agents) and gender (Women and Men).
An ageing male population, more men seeking care, less invasive procedures and telehealth for sensitive conditions are driving the urinary Incontinence Devices market.
Office-based procedures, direct-to-consumer telehealth and wider insurance coverage give the urinary Incontinence Devices market room to grow.
Stigma, out-of-pocket costs and limited reimbursement for some procedures hold back the urinary Incontinence Devices market.
The urinary Incontinence Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In the countries we cover here, medical devices are regulated by Health Canada (Canada)[1] and FDA (US)[2]. How care is paid for in these countries: provincial health insurance (Canada)[3] and Medicare and Medicaid (US)[4].
[1] Health Canada. Checked 14 Nov 2026.
[2] US Food and Drug Administration. Checked 14 Nov 2026.
[3] Health Canada. Checked 14 Nov 2026.
[4] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how urinary Incontinence Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in North America.
What doctors and scientists are doing in Urinary Incontinence Devices right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
North America
North America
North America
North America
North America
North America
Healthcare Services · North America
Digital Health · North America
Pharmaceuticals · North America
Pharmaceuticals · North America
Healthcare Services · North America
Pharmaceuticals · North America